Latest News
What was good for the bullish goose (sentiment extremes in March-April) is going to be good for bearish gander as well.
Via Talk Markets · May 12, 2025

Investors and managers digest the trade prospects and argue over the outcomes; while we have focused on selected non-big-cap stocks for the most part; seeking to stay out of the political circus center-ring antics.
Via Talk Markets · May 12, 2025
The proxy advisory firm recommended voting for three of Elliott’s nominees at Phillips 66’s annual shareholder meeting on May 21.
Via Stocktwits · May 12, 2025
The past quarter saw big tournaments like the Super Bowl, where the underdog Philadelphia Eagles clinched victory, and March Madness.
Via Stocktwits · May 12, 2025
Eli Lilly’s Zepbound led to 47% greater weight loss than Wegovy in a 72-week trial, yet retail sentiment turned bearish on Stocktwits amid heightened scrutiny on drug pricing following Trump’s vow to slash U.S. prescription costs by up to 80%.
Via Stocktwits · May 11, 2025
We discuss key macro triggers that could disrupt the current market calm.
Via Talk Markets · May 11, 2025
The U.S. shrinkage for the first quarter comes to about $24 billion. It’s roughly 0.075 percent of our $30 trillion GDP.
Via Talk Markets · May 11, 2025
Prominent economists offered mixed reactions Sunday as markets rallied following announcement of a tentative U.S.-China trade agreement reached during weekend talks in Geneva, with futures surging on optimism despite limited details of the actual terms.
Via Benzinga · May 11, 2025
TMTG said it focused on building its ecosystem, improving its existing platforms, and diversifying into financial services in the first quarter.
Via Stocktwits · May 11, 2025
Strategy Inc. (NASDAQ:MSTR) executive chairman Michael Saylor on Sunday posted a cute AI-generated video of his child persona discussing Bitcoin’s (CRYPTO: BTC) optimistic outlook with cryptocurrency
Via Benzinga · May 11, 2025
Key supports lie at 24,000 and 23,800, with traders advised to stay nimble amid volatility.
Via Stocktwits · May 11, 2025
The company's report is an outlier as most retail businesses flag weak demand and cost pressures from U.S. trade policies.
Via Stocktwits · May 11, 2025
U.S. District Judge Steven Logan said Apache Stronghold will likely succeed in its appeal to the U.S. Supreme Court against the mine.
Via Stocktwits · May 11, 2025
Odds that the U.S. would plunge into recession in 2025 dipped below 50% on decentralized prediction market Polymarket after the U.S. announced a trade deal with China on Sunday.
Via Benzinga · May 11, 2025
The proposal, citing a "Most Favored Nation Policy," fueled debate prompted some watchers to question the legality and feasibility of the move, while others speculated on its potential market impact.
Via Stocktwits · May 11, 2025
U.S. Trade Representative Jamieson Greer stated that the speed with which the U.S. and China could reach an agreement showed that perhaps the differences were not as large as initially thought.
Via Stocktwits · May 11, 2025
Trump vows to slash drug prices with new executive order, potentially dropping them by 30-80%.
Via Benzinga · May 11, 2025
All of its outlets, including Popeyes and Tim Hortons, saw their same-store sales decline.
Via Stocktwits · May 11, 2025
An economy in which consumption is the number one driver there can be elements of adjustment in which the benefit for the overall economy for everybody may come from being a little bit more prudent about consumption
Via Talk Markets · May 11, 2025
U.S. stock futures rose Sunday evening after weekend trade talks in Geneva signaled potential de-escalation in the ongoing trade war with China.
Via Benzinga · May 11, 2025
Short interest in Hims & Hers rose to a record high of 37%, continuing a four-week climb, even as the stock surged 42% last week. The company’s quarterly revenue more than doubled, surpassing analyst expectations.
Via Stocktwits · May 11, 2025
Leading cryptocurrencies held on to gains Sunday as the U.S. announced a trade deal with China.
Via Benzinga · May 11, 2025
Despite soaring short interest, retail sentiment remains bullish, with investors optimistic about the company’s positive trial results and the continued demand for its FDA-approved treatment, Rezdiffra.
Via Stocktwits · May 11, 2025
The analyst said his checks revealed increased momentum for the company’s cyber platform approach into the next year.
Via Stocktwits · May 11, 2025